Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - VaxGen, Inc. (NasdaqNM:VXGN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Recent Events
Aug 30Price hit new 52-week low ($11.60)
Location
1000 Marina Blvd., Suite 200
Brisbane, CA 94005
Phone: (650) 624-1000
Fax: (650) 624-1001
Email: webmaster@vaxgen.com
Employees (last reported count): 78
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 63%
·Over the last 6 months:
 · 7 insider sells; 698.0K shares
  (7.2% of insider shares)
·Institutional: 10% (28% of float)
(77 institutions)
·Net Inst. Buying: 118.0K shares (+7.43%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
VaxGen, Inc. was formed to complete the development of, and commercialize, AIDSVAX, a preventive HIV (Human Immunodeficiency Virus) vaccine. The original AIDSVAX technology was developed by Genentech and then licensed exclusively to the Company. VaxGen is currently testing AIDSVAX in humans in two large-scale Phase III clinical trials. The Company's vaccine is designed to prevent infection by HIV, rather than treat established infection. The Company has commenced clinical trials in North America and Europe, as well as one in Thailand, to determine the efficacy of AIDSVAX.
More from Market Guide: Expanded Business Description

Financial Summary
VaxGen, Inc. is a development stage biotechnology company formed to develop a vaccine intended to prevent HIV infection. For the six months ended 6/30/01, revenues rose from $0 thousand to $421 thousand. Net loss applicable to Common rose 26% to $12.8 million. Revenues reflect $346 thousand in revenue from a project funded by the National Institute of Allergy and Infectious Diseases. Higher loss reflects higher personnel costs and professional service fees and $1 million in preferred stock costs.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Pay

Donald Francis, M.D., 57
Pres, CEO, Director
$275K
Carter Lee, 47
Sr. VP, Fin. & Admin.
185K
Phillip Berman, Ph.D., 50
Sr. VP, R&D
200K
John Curd, M.D., 54
Sr. VP, Medical Affairs
150K
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:VXGNAs of 31-Aug-2001
Price and Volume
52-Week Low
on 30-Aug-2001
$11.60 
Recent Price$12.10 
52-Week High
on 26-Oct-2000
$36.875
Beta1.44 
Daily Volume (3-month avg)127.6K
Daily Volume (10-day avg)90.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-53.9%
52-Week Change
relative to S&P500
-38.2%
Share-Related Items
Market Capitalization$171.6M
Shares Outstanding14.2M
Float5.20M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$3.15 
Earnings (ttm)-$2.48 
Earnings (mrq)-$0.49 
Sales (ttm)$0.05 
Cash (mrq)$4.04 
Valuation Ratios
Price/Book (mrq)3.85 
Price/EarningsN/A 
Price/Sales (ttm)241.65 
Income Statements
Sales (ttm)$696.0K
EBITDA (ttm)-$36.0M
Income available to common (ttm)-$34.4M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-56.44%
Return on Equity (ttm)-66.20%
Financial Strength
Current Ratio (mrq)17.36 
Debt/Equity (mrq)0.00 
Total Cash (mrq)$57.3M
Short Interest
As of 8-Aug-2001
Shares Short1.21M
Percent of Float23.3%
Shares Short
(Prior Month)
1.12M
Short Ratio11.43 
Daily Volume106.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.